// App-Quantinova.ai

e14004 : Development of algorithms for a quantitative real time-PCR assay to determine EGFRvIII status in glioblastoma patients from rindopepimut clinical trials.

Researchers

Presenter

  • Jim Yan

Principal Investigators

  • Donald James Witt

  • Li Cai

  • Marcia Eisenberg

  • Abdel Halim

  • Don Kafader

  • Alan Wookey

  • Steve Anderson

Medical Centers

  • Laboratory Corporation of Amcerica, Research Triangle Park, NC

  • LabCorp, Durham, NCCelldex Therapeutics, Hampton, NJLaboratory Corporation of America, Cranford, NJ

  • LabCorp Clinical Trials, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • Rindopepimut

  • EGFRvIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved